Gustavo Ferreira Alves Selected Research

Gustavo Ferreira Alves Research Topics

3	Inflammation (Inflammations) 02/2024 - 08/2020
3	Obesity 02/2024 - 01/2021
2	Insulin Resistance 02/2024 - 01/2021
2	Hemorrhagic Shock 01/2024 - 07/2023
2	Wounds and Injuries (Trauma) 01/2024 - 07/2023
2	Multiple Organ Failure (MODS) 07/2023 - 01/2020
1	Glucose Intolerance 02/2024
1	Fibrosis (Cirrhosis) 02/2024
1	Hemorrhage 07/2023
1	Proteinuria 01/2021
1	Fatty Liver 01/2021
1	Hypercholesterolemia 01/2021
1	Sepsis (Septicemia) 01/2020

2	CytokinesIBA 02/2024 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2021
1	Advanced Glycation End ProductsIBA 02/2024
1	Transaminases (Aminotransferases)IBA 02/2024
1	Glucose (Dextrose)FDA LinkGeneric 02/2024
1	(+)-JQ1 compoundIBA 02/2024
1	LipidsIBA 02/2024
1	Doxycycline (Periostat)FDA LinkGeneric 01/2024
1	baricitinibIBA 07/2023
1	Janus Kinase InhibitorsIBA 07/2023
1	Janus KinasesIBA 07/2023
1	Pep19-2.5 peptideIBA 01/2021
1	InflammasomesIBA 01/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 08/2020
1	IncretinsIBA 08/2020
1	Dietary Advanced Glycation End ProductsIBA 08/2020
1	acalabrutinibIBA 01/2020
1	ibrutinibIBA 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020

1	Resuscitation 07/2023